Interference detector for patient monitor
-
0Associated
Cases -
0Associated
Defendants -
0Accused
Products -
27Forward
Citations -
0
Petitions -
1
Assignment
First Claim
1. A noninvasive monitor configured to communicate with a sensor including an optical radiation source and one or more detectors housed in a sensor housing, the sensor housing configured to position the optical radiation source and the one or more detectors proximate tissue of a patient, the noninvasive monitor comprising:
- an input configured to receive from the sensor first sensor signals responsive to detected light from the optical radiation source attenuated by the tissue and second sensor signals responsive to detected ambient electronic interference proximate the sensor; and
a hardware processor configured to;
process the first sensor signals to determine a first measurement value for a first physiological parameter of the patient and a second measurement value for a second physiological parameter of the patient without using the second sensor signals to determine the first measurement value and the second measurement value, the first physiological parameter being different from the second physiological parameter, the first physiological parameter corresponding to a first threshold and the second physiological parameter corresponding to a second threshold different from the first threshold,process the second sensor signals differently from the first sensor signals to determine a first level of ambient electronic interference proximate the sensor and a second level of ambient electronic interference proximate the sensor,determine at least one of a first audio or visual indication from a comparison of the first level of ambient electronic interference to the first threshold, the at least one of the first audio or visual indication indicating a suitability of a testing environment for patient monitoring for the first physiological parameter and indicating a degree to which relocating the sensor could reduce ambient electronic interference proximate the sensor,determine at least one of a second audio or visual indication from a comparison of the second level of ambient electronic interference to the second threshold, the at least one of the second audio or visual indication indicating a suitability of the testing environment for patient monitoring for the second physiological parameter and indicating a degree to which relocating the sensor could reduce ambient electronic interference proximate the sensor,output the at least one of the first audio or visual indication for presentation prior to outputting the first measurement value for presentation, andoutput the at least one of the second audio or visual indication for presentation prior to outputting the second measurement value for presentation.
1 Assignment
0 Petitions

Accused Products

Abstract
A system is disclosed for detecting and calculating the level of ambient and/or environmental noise, such as electromagnetic interference generated by electric power lines, ambient lights, light dimmers, television or computer displays, power supplies or transformers, and medical equipment. In some embodiments, the system performs frequency analysis on the interference signal detected by light photodetectors and determines the power of the interference signal concentrated in the analyzed frequency bands. The worst-case interference level can be determined by selecting the maximum from the computed power values. In some embodiments, the determined interference signal power can be compared with the noise tolerance of a patient monitoring system configured to reliably and noninvasively detect physiological parameters of a user. The results of the comparison can be presented to the user audio-visually. In some embodiments, the system can be used to perform spot check measurements of electromagnetic interference.
324 Citations
Non-invasive physiological sensor cover | ||
Patent #
US 10,188,331 B1
Filed 10/02/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive physiological sensor cover | ||
Patent #
US 10,194,848 B1
Filed 10/02/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Magnetic connector | ||
Patent #
US 10,205,272 B2
Filed 10/07/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pogo pin connector | ||
Patent #
US 10,205,291 B2
Filed 02/05/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Arm mountable portable patient monitor | ||
Patent #
US 10,213,108 B2
Filed 03/03/2017
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological measurement device | ||
Patent #
US 10,219,706 B2
Filed 10/11/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Oximeter probe off indicator defining probe off space | ||
Patent #
US 10,219,746 B2
Filed 06/20/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient-worn wireless physiological sensor | ||
Patent #
US 10,226,187 B2
Filed 08/31/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological parameter alarm delay | ||
Patent #
US 10,255,994 B2
Filed 02/12/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Monitor configuration system | ||
Patent #
US 10,292,664 B2
Filed 07/29/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological alarm threshold determination | ||
Patent #
US 10,325,681 B2
Filed 02/12/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Fold flex circuit for LNOP | ||
Patent #
US 10,327,337 B2
Filed 02/05/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Modular multi-parameter patient monitoring device | ||
Patent #
US 10,327,713 B2
Filed 02/23/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological monitor | ||
Patent #
US 10,335,072 B2
Filed 11/14/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological measurement device | ||
Patent #
US 10,335,033 B2
Filed 11/21/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Modular patient monitor | ||
Patent #
US 10,354,504 B2
Filed 11/15/2017
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological alarm threshold determination | ||
Patent #
US 10,366,787 B2
Filed 02/12/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Flowometry in optical coherence tomography for analyte level estimation | ||
Patent #
US 10,368,787 B2
Filed 05/13/2015
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Wireless patient monitoring systems and methods | ||
Patent #
US 10,383,527 B2
Filed 08/31/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Localized projection of audible noises in medical settings | ||
Patent #
US 10,388,120 B2
Filed 02/26/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Hemoglobin display and patient treatment | ||
Patent #
US 10,413,666 B2
Filed 10/20/2017
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low power pulse oximeter | ||
Patent #
US 10,433,776 B2
Filed 10/29/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for patient fall detection | ||
Patent #
US 10,448,844 B2
Filed 08/31/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Advanced pulse oximetry sensor | ||
Patent #
US 10,448,871 B2
Filed 06/28/2016
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Optical sensor including disposable and reusable elements | ||
Patent #
US 10,463,284 B2
Filed 12/04/2017
|
Current Assignee
Masimo Laboratories Inc.
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Advanced pulse oximetry sensor | ||
Patent #
US 10,470,695 B2
Filed 12/19/2018
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive physiological sensor cover | ||
Patent #
US 10,478,107 B2
Filed 05/24/2019
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Sine saturation transform | ||
Patent #
US 7,904,132 B2
Filed 12/16/2008
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Variable indication estimator | ||
Patent #
US 7,873,497 B2
Filed 01/29/2009
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive measurement of second heart sound components | ||
Patent #
US 7,909,772 B2
Filed 04/15/2005
|
Current Assignee
ANDROMED INC.
|
Sponsoring Entity
ANDROMED INC.
|
Physiological trend monitor | ||
Patent #
US 7,880,606 B2
Filed 02/12/2008
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological monitor | ||
Patent #
US 7,899,507 B2
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for indicating an amount of use of a sensor | ||
Patent #
US 7,910,875 B2
Filed 03/06/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for reducing coupling between signals in a measurement system | ||
Patent #
US 7,865,222 B2
Filed 01/23/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Non-invasive tissue glucose level monitoring | ||
Patent #
US 7,899,518 B2
Filed 09/12/2005
|
Current Assignee
Masimo Laboratories Inc.
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Physiological monitor | ||
Patent #
US 7,891,355 B2
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
System and method for monitoring the life of a physiological sensor | ||
Patent #
US 7,880,626 B2
Filed 10/12/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological monitor | ||
Patent #
US 7,894,868 B2
Filed 05/05/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Variable aperture sensor | ||
Patent #
US 7,937,129 B2
Filed 03/21/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Cyanotic infant sensor | ||
Patent #
US 7,937,128 B2
Filed 06/30/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,937,130 B2
Filed 12/19/2008
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Robust alarm system | ||
Patent #
US 7,962,188 B2
Filed 10/12/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
INTERFERENCE DETECTOR FOR PATIENT MONITOR | ||
Patent #
US 20110109459A1
Filed 07/22/2010
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low noise oximetry cable including conductive cords | ||
Patent #
US 7,919,713 B2
Filed 04/16/2008
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 7,951,086 B2
Filed 11/12/2009
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Physiological parameter confidence measure | ||
Patent #
US 7,957,780 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Sepsis monitor | ||
Patent #
US 7,941,199 B2
Filed 05/15/2007
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Cercacor Laboratories
|
Signal processing apparatus | ||
Patent #
US 7,962,190 B1
Filed 07/07/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Virtual display | ||
Patent #
US 7,990,382 B2
Filed 01/03/2007
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors | ||
Patent #
US 8,008,088 B2
Filed 06/26/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Plethysmograph pulse recognition processor | ||
Patent #
US 7,988,637 B2
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 8,019,400 B2
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for acquiring calibration data usable in a pulse oximeter | ||
Patent #
US 7,991,446 B2
Filed 05/08/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Resposable pulse oximetry sensor | ||
Patent #
US 8,000,761 B2
Filed 05/02/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Noninvasive hypovolemia monitor | ||
Patent #
US 7,976,472 B2
Filed 09/06/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 8,046,041 B2
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry data confidence indicator | ||
Patent #
US 8,046,040 B2
Filed 04/04/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Respiratory monitoring | ||
Patent #
US 8,028,701 B2
Filed 05/31/2007
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors | ||
Patent #
US 8,029,765 B2
Filed 12/23/2004
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Fluid titration system | ||
Patent #
US 8,048,040 B2
Filed 09/11/2008
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Multiple wavelength sensor drivers | ||
Patent #
US 8,050,728 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Signal processing apparatus | ||
Patent #
US 8,036,728 B2
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 8,046,042 B2
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Multiple wavelength sensor equalization | ||
Patent #
US 7,647,083 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Multiple wavelength sensor emitters | ||
Patent #
US 7,764,982 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Physiological measurement communications adapter | ||
Patent #
US 7,844,315 B2
Filed 05/03/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological monitor | ||
Patent #
US 7,761,128 B2
Filed 04/13/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Physiological measurement communications adapter | ||
Patent #
US 7,844,314 B2
Filed 02/01/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Multiple wavelength sensor substrate | ||
Patent #
US 7,761,127 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Configurable physiological measurement system | ||
Patent #
US 7,729,733 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Optical spectroscopy pathlength measurement system | ||
Patent #
US 7,801,581 B2
Filed 12/11/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Cercacor Laboratories
|
NON-INTERFERING PHYSIOLOGICAL SENSOR SYSTEM | ||
Patent #
US 20100087718A1
Filed 08/18/2009
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Method for data reduction and calibration of an OCT-based blood glucose monitor | ||
Patent #
US 7,822,452 B2
Filed 04/13/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
GLT Acquisition Corporation
|
Sensor isolation | ||
Patent #
US 7,734,320 B2
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Detector shield | ||
Patent #
US 7,791,155 B2
Filed 12/21/2007
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Cercacor Laboratories
|
Pulse oximetry sensor adapter | ||
Patent #
US 7,844,313 B2
Filed 01/27/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter access apparatus and method | ||
Patent #
US 7,483,729 B2
Filed 11/04/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes for reducing ambient noise | ||
Patent #
US 7,483,730 B2
Filed 10/04/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 7,489,958 B2
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,496,393 B2
Filed 09/30/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Manual and automatic probe calibration | ||
Patent #
US 7,496,391 B2
Filed 01/13/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Variable indication estimator | ||
Patent #
US 7,499,835 B2
Filed 03/14/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
OCT based method for diagnosis and therapy | ||
Patent #
US 7,510,849 B2
Filed 01/21/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
GlucoLight Corporation
|
Multipurpose sensor port | ||
Patent #
US 7,500,950 B2
Filed 07/23/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Interface cable | ||
Patent #
US 7,509,494 B2
Filed 02/28/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 7,499,741 B2
Filed 05/04/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,509,154 B2
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Manual and automatic probe calibration | ||
Patent #
US 7,526,328 B2
Filed 12/15/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Remote sensing infant warmer | ||
Patent #
US 7,530,942 B1
Filed 10/18/2006
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,530,955 B2
Filed 05/04/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Dual-mode pulse oximeter | ||
Patent #
US 7,530,949 B2
Filed 08/03/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA | ||
Patent #
US 20090156924A1
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Sponsoring Entity
DexCom Incorporated
|
Multiple wavelength sensor interconnect | ||
Patent #
US 7,563,110 B2
Filed 05/23/2008
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Method for the presentation of information concerning variations of the perfusion | ||
Patent #
US 7,572,230 B2
Filed 10/02/2003
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
Koninklijke Philips N.V.
|
Multiple wavelength sensor attachment | ||
Patent #
US 7,596,398 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 7,618,375 B2
Filed 04/28/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method of providing an optoelectronic element with a non-protruding lens | ||
Patent #
US 7,332,784 B2
Filed 06/27/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,328,053 B1
Filed 11/17/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
METHOD AND APPARATUS FOR DEMODULATING SIGNALS IN A PULSE OXIMETRY SYSTEM | ||
Patent #
US 20080033265A1
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Multi-wavelength physiological monitor | ||
Patent #
US 7,343,186 B2
Filed 05/27/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Flex circuit shielded optical sensor | ||
Patent #
US 7,340,287 B2
Filed 12/02/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry ear sensor | ||
Patent #
US 7,341,559 B2
Filed 07/31/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Parallel alarm processor | ||
Patent #
US 7,355,512 B1
Filed 03/13/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for tissue oximetry | ||
Patent #
US 7,356,365 B2
Filed 07/02/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
GlucoLight Corporation
|
Signal processing apparatus | ||
Patent #
US 7,376,453 B1
Filed 09/01/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal component processor | ||
Patent #
US 7,373,194 B2
Filed 02/01/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry data capture system | ||
Patent #
US 7,373,193 B2
Filed 11/05/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Multiple wavelength sensor interconnect | ||
Patent #
US 7,377,794 B2
Filed 03/01/2006
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Connector switch | ||
Patent #
US 7,371,981 B2
Filed 02/18/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Sine saturation transform | ||
Patent #
US 7,377,899 B2
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,383,070 B2
Filed 12/03/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Physiological parameter system | ||
Patent #
US 7,415,297 B2
Filed 03/08/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for acquiring calibration data usable in a pulse oximeter | ||
Patent #
US 7,428,432 B2
Filed 04/22/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Application identification sensor | ||
Patent #
US 7,438,683 B2
Filed 03/03/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for determining blood oxygen saturation values using complex number encoding | ||
Patent #
US 7,440,787 B2
Filed 11/28/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Signal processing apparatus | ||
Patent #
US 7,454,240 B2
Filed 05/11/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,469,157 B2
Filed 02/13/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Sine saturation transform | ||
Patent #
US 7,467,002 B2
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter probe-off detector | ||
Patent #
US 7,471,969 B2
Filed 11/25/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 7,471,971 B2
Filed 03/02/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Techniques for detecting heart pulses and reducing power consumption in sensors | ||
Patent #
US 7,162,288 B2
Filed 02/25/2004
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett LLC
|
Method and circuit for storing and providing historical physiological data | ||
Patent #
US 20070043269A1
Filed 06/01/2006
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Arrhythmia alarm processor | ||
Patent #
US 7,190,261 B2
Filed 04/18/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Amount of use tracking device and method for medical product | ||
Patent #
US 7,186,966 B2
Filed 12/19/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,215,986 B2
Filed 06/15/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,215,984 B2
Filed 05/04/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Optical sensor including disposable and reusable elements | ||
Patent #
US 7,225,007 B2
Filed 06/30/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Attachment and optical probe | ||
Patent #
US 7,225,006 B2
Filed 01/23/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for demodulating signals in a pulse oximetry system | ||
Patent #
US 7,221,971 B2
Filed 12/19/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Active pulse blood constituent monitoring | ||
Patent #
US 7,239,905 B2
Filed 08/16/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Reusable pulse oximeter probe and disposable bandage apparatii | ||
Patent #
US 7,245,953 B1
Filed 11/05/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Variable pressure reusable sensor | ||
Patent #
US 7,254,434 B2
Filed 10/13/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,254,433 B2
Filed 09/30/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for monitoring glucose levels in a biological tissue | ||
Patent #
US 7,254,429 B2
Filed 08/11/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
GlucoLight Corporation
|
Physiological parameter tracking system | ||
Patent #
US 7,254,431 B2
Filed 08/30/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Parameter compensated pulse oximeter | ||
Patent #
US 7,274,955 B2
Filed 09/25/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry sensor including stored sensor data | ||
Patent #
US 7,272,425 B2
Filed 09/26/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry sensor | ||
Patent #
US 7,280,858 B2
Filed 01/04/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Multivariate analysis of green to ultraviolet spectra of cell and tissue samples | ||
Patent #
US 7,289,835 B2
Filed 06/02/2005
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Low power pulse oximeter | ||
Patent #
US 7,295,866 B2
Filed 02/24/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological assessment system | ||
Patent #
US 7,292,883 B2
Filed 03/30/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Induced fluorescence spectroscopy blood perfusion and pH monitor and method | ||
Patent #
US 5,456,252 A
Filed 09/30/1993
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Variable mode averager | ||
Patent #
US 6,430,525 B1
Filed 06/05/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Glucose fluorescence monitor and method | ||
Patent #
US 5,341,805 A
Filed 04/06/1993
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Optoelectronic element with a non-protruding lens | ||
Patent #
US 7,067,893 B2
Filed 01/03/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Non-protruding optoelectronic lens | ||
Patent #
US 6,525,386 B1
Filed 03/10/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Variable indication estimator | ||
Patent #
US 6,999,904 B2
Filed 08/05/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Mold tool for an optoelectronic element | ||
Patent #
US 6,830,711 B2
Filed 01/03/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Flex circuit shielded optical sensor | ||
Patent #
US 6,985,764 B2
Filed 05/02/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry sensor adaptor | ||
Patent #
US 6,993,371 B2
Filed 07/22/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry data confidence indicator | ||
Patent #
US 6,996,427 B2
Filed 12/18/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for demodulating signals in a pulse oximetry system | ||
Patent #
US 7,003,339 B2
Filed 11/03/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for reducing coupling between signals | ||
Patent #
US 7,003,338 B2
Filed 07/08/2003
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Corporation
|
Power supply rail controller | ||
Patent #
US 7,015,451 B2
Filed 01/24/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Parallel measurement alarm processor | ||
Patent #
US 7,030,749 B2
Filed 10/28/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Blood parameter measurement system | ||
Patent #
US 7,027,849 B2
Filed 11/21/2003
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Pulse oximetry data confidence indicator | ||
Patent #
US 7,024,233 B2
Filed 09/16/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Plethysmograph pulse recognition processor | ||
Patent #
US 7,044,918 B2
Filed 10/27/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 7,041,060 B2
Filed 09/06/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Resposable pulse oximetry sensor | ||
Patent #
US 7,039,449 B2
Filed 12/19/2003
|
Current Assignee
CFS BUHL GMBH
|
Sponsoring Entity
CFS BUHL GMBH
|
Blind source separation of pulse oximetry signals | ||
Patent #
US 7,079,880 B2
Filed 09/29/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett LLC
|
Method for the presentation of information concerning variations of the perfusion | ||
Patent #
US 20060167362A1
Filed 10/02/2003
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
Koninklijke Philips N.V.
|
Low noise optical housing | ||
Patent #
US 7,096,054 B2
Filed 07/31/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Optical probe including predetermined emission wavelength based on patient type | ||
Patent #
US 7,096,052 B2
Filed 10/06/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Parameter compensated physiological monitor | ||
Patent #
US 7,142,901 B2
Filed 11/14/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Shielded optical probe having an electrical connector | ||
Patent #
US 7,132,641 B2
Filed 03/31/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Optical spectroscopy pathlength measurement system | ||
Patent #
US 7,149,561 B2
Filed 10/28/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
System and method of determining whether to recalibrate a blood pressure monitor | ||
Patent #
US 6,852,083 B2
Filed 01/17/2002
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Physiological measurement communications adapter | ||
Patent #
US 6,850,788 B2
Filed 02/28/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal component processor | ||
Patent #
US 6,850,787 B2
Filed 06/26/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for indicating an amount of use of a sensor | ||
Patent #
US 6,861,639 B2
Filed 02/03/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Stereo pulse oximeter | ||
Patent #
US 6,898,452 B2
Filed 09/22/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Optical sensor including disposable and reusable elements | ||
Patent #
US 6,920,345 B2
Filed 01/24/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Physiological sensor combination | ||
Patent #
US 6,934,570 B2
Filed 12/19/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Active pulse blood constituent monitoring | ||
Patent #
US 6,931,268 B1
Filed 11/06/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Isolation and communication element for a resposable pulse oximetry sensor | ||
Patent #
US 6,950,687 B2
Filed 01/24/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 6,939,305 B2
Filed 10/14/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
System for detecting injection holding material | ||
Patent #
US 6,943,348 B1
Filed 10/19/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for determining blood oxygen saturation values using complex number encoding | ||
Patent #
US 6,970,792 B1
Filed 12/03/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Pulse and active pulse spectraphotometry | ||
Patent #
US 6,961,598 B2
Filed 02/21/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Systems and methods for indicating an amount of use of a sensor | ||
Patent #
US 6,979,812 B2
Filed 02/24/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Optical probe and positioning wrap | ||
Patent #
US 6,678,543 B2
Filed 11/08/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Reusable pulse oximeter probe and disposable bandage method | ||
Patent #
US 6,684,091 B2
Filed 01/11/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Pulse oximetry data confidence indicator | ||
Patent #
US 6,684,090 B2
Filed 05/15/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and devices for laser induced fluorescence attenuation spectroscopy (LIFAS) | ||
Patent #
US 6,697,657 B1
Filed 06/28/2000
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Pulse oximetry sensor compatible with multiple pulse oximetry systems | ||
Patent #
US 6,697,656 B1
Filed 06/27/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low power pulse oximeter | ||
Patent #
US 6,697,658 B2
Filed 06/26/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Stereo pulse oximeter | ||
Patent #
US 6,714,804 B2
Filed 12/21/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 6,699,194 B1
Filed 04/11/2000
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices | ||
Patent #
US 6,721,585 B1
Filed 08/17/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Resposable pulse oximetry sensor | ||
Patent #
US 6,725,075 B2
Filed 04/23/2002
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive tissue glucose level monitoring | ||
Patent #
US 6,728,560 B2
Filed 02/28/2002
|
Current Assignee
General Hospital Corporation
|
Sponsoring Entity
General Hospital Corporation
|
Non-invasive tissue glucose level monitoring | ||
Patent #
US 6,721,582 B2
Filed 02/20/2001
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
General Hospital Corporation
|
Network formatting for remote location oximetry applications | ||
Patent #
US 20040102687A1
Filed 07/02/2002
|
Current Assignee
James Galbiati
|
Sponsoring Entity
James Galbiati
|
Reusable pulse oximeter probe and disposable bandage apparatus | ||
Patent #
US 6,735,459 B2
Filed 09/09/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Signal processing apparatus | ||
Patent #
US 6,745,060 B2
Filed 12/03/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Ribbon cable substrate pulse oximetry sensor | ||
Patent #
US 6,760,607 B2
Filed 12/20/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Dual-mode pulse oximeter | ||
Patent #
US 6,770,028 B1
Filed 08/18/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter probe-off detection system | ||
Patent #
US 6,771,994 B2
Filed 02/24/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes for reducing light piping | ||
Patent #
US 6,792,300 B1
Filed 07/03/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes for reducing ambient noise | ||
Patent #
US 6,813,511 B2
Filed 09/27/2002
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Plethysmograph pulse recognition processor | ||
Patent #
US 6,816,741 B2
Filed 10/08/2002
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 6,826,419 B2
Filed 12/20/2002
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Parallel measurement alarm processor | ||
Patent #
US 6,822,564 B2
Filed 01/24/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive tissue glucose level monitoring | ||
Patent #
US 6,505,059 B1
Filed 04/06/1999
|
Current Assignee
General Hospital Corporation
|
Sponsoring Entity
General Hospital Corporation
|
Reusable pulse oximeter probe and disposable bandage apparatus | ||
Patent #
US 6,519,487 B1
Filed 10/05/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
System for indicating the expiration of the useful operating life of a pulse oximetry sensor | ||
Patent #
US 6,515,273 B2
Filed 02/10/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter probe-off detection system | ||
Patent #
US 6,526,300 B1
Filed 06/16/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Shielded optical probe having an electrical connector | ||
Patent #
US 6,541,756 B2
Filed 01/25/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter monitor for expressing the urgency of the patient's condition | ||
Patent #
US 6,542,764 B1
Filed 12/01/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Shielded optical probe and method | ||
Patent #
US 6,580,086 B1
Filed 10/19/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Universal/upgrading pulse oximeter | ||
Patent #
US 6,584,336 B1
Filed 03/01/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry sensor adapter | ||
Patent #
US 6,597,933 B2
Filed 10/17/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Generation of spatially-averaged excitation-emission map in heterogeneous tissue | ||
Patent #
US 6,597,932 B2
Filed 02/20/2001
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
ARGOSE INC.
|
Tension-adjustable mechanism for stethoscope earpieces | ||
Patent #
US 6,595,316 B2
Filed 07/18/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
ANDROMED INC.
|
Pulse oximetry pulse indicator | ||
Patent #
US 6,606,511 B1
Filed 01/06/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Optical spectroscopy pathlength measurement system | ||
Patent #
US 6,640,116 B2
Filed 08/09/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Asynchronous fluorescence scan | ||
Patent #
US 6,639,668 B1
Filed 11/03/2000
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
ARGOSE INC.
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 6,632,181 B2
Filed 10/05/1999
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 6,650,917 B2
Filed 12/04/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for demodulating signals in a pulse oximetry system | ||
Patent #
US 6,643,530 B2
Filed 12/13/2000
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter probe-off detector | ||
Patent #
US 6,654,624 B2
Filed 12/19/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Piezoelectric biological sound monitor with printed circuit board | ||
Patent #
US 6,661,161 B1
Filed 06/27/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
ANDROMED INC.
|
Pulse oximeter user interface | ||
Patent #
US 6,658,276 B2
Filed 02/12/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Sensor wrap including foldable applicator | ||
Patent #
US 6,671,531 B2
Filed 12/11/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Reusable pulse oximeter probe and disposable bandage apparatus | ||
Patent #
US 6,343,224 B1
Filed 10/14/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Pulse oximetry sensor adapter | ||
Patent #
US 6,349,228 B1
Filed 09/23/1999
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter probe-off detector | ||
Patent #
US 6,360,114 B1
Filed 03/21/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for estimating systolic and mean pulmonary artery pressures of a patient | ||
Patent #
US 6,368,283 B1
Filed 09/08/2000
|
Current Assignee
Universite Laval, Institut De Recherches Cliniques De Montreal
|
Sponsoring Entity
Universite Laval, Institut De Recherches Cliniques De Montreal
|
System and method of determining whether to recalibrate a blood pressure monitor | ||
Patent #
US 6,371,921 B1
Filed 11/01/1999
|
Current Assignee
VITAL INSITE INCORPORATED
|
Sponsoring Entity
VITAL INSITE INCORPORATED
|
Resposable pulse oximetry sensor | ||
Patent #
US 6,377,829 B1
Filed 12/09/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Manual and automatic probe calibration | ||
Patent #
US 6,397,091 B2
Filed 11/30/1999
|
Current Assignee
The United States of America As Represented By The Secretary of Agriculture
|
Sponsoring Entity
The United States of America As Represented By The Secretary of Agriculture
|
Shielded optical probe and method having a longevity indication | ||
Patent #
US 6,388,240 B2
Filed 03/02/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Module for acquiring electroencephalograph signals from a patient | ||
Patent #
US 6,430,437 B1
Filed 10/27/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Physiometrix Inc.
|
Elastic sock for positioning an optical probe | ||
Patent #
US 6,470,199 B1
Filed 06/21/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Plethysmograph pulse recognition processor | ||
Patent #
US 6,463,311 B1
Filed 12/23/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 6,501,975 B2
Filed 01/09/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Photodiode detector with integrated noise shielding | ||
Patent #
US 6,184,521 B1
Filed 01/06/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 6,206,830 B1
Filed 11/17/1999
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Glucose monitoring apparatus and method using laser-induced emission spectroscopy | ||
Patent #
US 6,232,609 B1
Filed 12/01/1995
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Method and apparatus for demodulating signals in a pulse oximetry system | ||
Patent #
US 6,229,856 B1
Filed 04/10/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 6,236,872 B1
Filed 11/25/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Phonospirometry for non-invasive monitoring of respiration | ||
Patent #
US 6,241,683 B1
Filed 02/22/1999
|
Current Assignee
McGill University
|
Sponsoring Entity
McGill University
|
Noninvasive medical monitoring instrument using surface emitting laser devices | ||
Patent #
US 6,253,097 B1
Filed 03/06/1996
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Signal processing apparatus | ||
Patent #
US 6,263,222 B1
Filed 10/06/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes | ||
Patent #
US 6,256,523 B1
Filed 06/09/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient cable connector | ||
Patent #
US 6,280,213 B1
Filed 11/07/2000
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Optical filter for spectroscopic measurement and method of producing the optical filter | ||
Patent #
US 6,278,522 B1
Filed 05/26/1999
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Fetal pulse oximetry sensor | ||
Patent #
US 6,285,896 B1
Filed 07/07/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Reservoir electrodes for electroencephalograph headgear appliance | ||
Patent #
US 6,301,493 B1
Filed 11/01/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Physiometrix Inc.
|
Anesthesia monitoring system based on electroencephalographic signals | ||
Patent #
US 6,317,627 B1
Filed 11/02/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Physiometrix Inc.
|
Reusable pulse oximeter probe with disposable liner | ||
Patent #
US 6,321,100 B1
Filed 07/13/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Device and method for measuring pulsus paradoxus | ||
Patent #
US 6,325,761 B1
Filed 02/28/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Gregory Jay
|
Stereo pulse oximeter | ||
Patent #
US 6,334,065 B1
Filed 05/27/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Manual and automatic probe calibration | ||
Patent #
US 6,011,986 A
Filed 02/02/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Rapid non-invasive blood pressure measuring device | ||
Patent #
US 6,027,452 A
Filed 06/26/1996
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITA INSITE INC.
|
Signal processing apparatus and method | ||
Patent #
US 6,036,642 A
Filed 06/22/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Apparatus and method for measuring an induced perturbation to determine a physiological parameter | ||
Patent #
US 6,045,509 A
Filed 02/19/1998
|
Current Assignee
VITAL INSITE INC.
|
Sponsoring Entity
VITAL INSITE INC.
|
Signal processing apparatus and method | ||
Patent #
US 6,067,462 A
Filed 05/19/1998
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 6,081,735 A
Filed 07/03/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low noise optical probe | ||
Patent #
US 6,088,607 A
Filed 01/28/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Blood glucose monitoring system | ||
Patent #
US 6,110,522 A
Filed 04/16/1998
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Method and devices for laser induced fluorescence attenuation spectroscopy | ||
Patent #
US 6,124,597 A
Filed 07/07/1997
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Device and method for measuring pulsus paradoxus | ||
Patent #
US 6,129,675 A
Filed 09/11/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Gregory Jay
|
Self adjusting headgear appliance using reservoir electrodes | ||
Patent #
US 6,128,521 A
Filed 07/10/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Physiometrix Inc.
|
Reusable pulse oximeter probe and disposable bandage apparatus | ||
Patent #
US 6,144,868 A
Filed 04/12/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Sensidyne Inc.
|
Active pulse blood constituent monitoring | ||
Patent #
US 6,151,516 A
Filed 11/12/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Circuit board based cable connector | ||
Patent #
US 6,152,754 A
Filed 12/21/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 6,157,850 A
Filed 05/16/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient cable sensor switch | ||
Patent #
US 6,165,005 A
Filed 12/07/1999
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Active pulse blood constituent monitoring method | ||
Patent #
US 5,860,919 A
Filed 04/17/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Shielded medical connector | ||
Patent #
US 5,890,929 A
Filed 06/03/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
-
|
Exciter-detector unit for measuring physiological parameters | ||
Patent #
US 5,904,654 A
Filed 02/26/1996
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
-
|
Method and apparatus for demodulating signals in a pulse oximetry system | ||
Patent #
US 5,919,134 A
Filed 01/12/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
-
|
Patient cable connector | ||
Patent #
US 5,934,925 A
Filed 04/09/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Optical filter for spectroscopic measurement and method of producing the optical filter | ||
Patent #
US 5,940,182 A
Filed 06/01/1998
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
-
|
Pulse oximetry sensor adapter | ||
Patent #
US 5,995,855 A
Filed 02/11/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 6,002,952 A
Filed 04/14/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient cable sensor switch | ||
Patent #
US 5,997,343 A
Filed 03/19/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient cable connector | ||
Patent #
D393830S
Filed 10/16/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Blood glucose monitoring system | ||
Patent #
US 5,743,262 A
Filed 06/07/1995
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus and method | ||
Patent #
US 5,769,785 A
Filed 06/07/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Manual and automatic probe calibration | ||
Patent #
US 5,758,644 A
Filed 06/07/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Optical filter for spectroscopic measurement and method of producing the optical filter | ||
Patent #
US 5,760,910 A
Filed 06/07/1995
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes | ||
Patent #
US 5,782,757 A
Filed 10/16/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Automatically activated blood pressure measurement device | ||
Patent #
US 5,785,659 A
Filed 05/17/1996
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Vital Insite Inc.
|
Motion insensitive pulse detector | ||
Patent #
US 5,791,347 A
Filed 08/14/1996
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Apparatus and method for measuring an induced perturbation to determine a physiological parameter | ||
Patent #
US 5,810,734 A
Filed 11/22/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Manual and automatic probe calibration | ||
Patent #
US 5,823,950 A
Filed 11/12/1996
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Apparatus and method for measuring an induced perturbation to determine a physiological parameter | ||
Patent #
US 5,833,618 A
Filed 11/22/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Apparatus and method for measuring an induced perturbation to determine a physical condition of the human arterial system | ||
Patent #
US 5,830,131 A
Filed 11/22/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Apparatus and method for measuring an induced perturbation to determine blood pressure | ||
Patent #
US 5,590,649 A
Filed 04/15/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Electronic stethescope | ||
Patent #
US 5,602,924 A
Filed 12/09/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
ANDROMED INC.
|
Signal processing apparatus | ||
Patent #
US 5,632,272 A
Filed 10/07/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low noise optical probe | ||
Patent #
US 5,638,818 A
Filed 11/01/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Active pulse blood constituent monitoring | ||
Patent #
US 5,638,816 A
Filed 06/07/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Patient cable connector | ||
Patent #
US 5,645,440 A
Filed 10/16/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 5,685,299 A
Filed 12/14/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
EEG headpiece with disposable electrodes and apparatus and system and method for use therewith | ||
Patent #
US 5,479,934 A
Filed 09/23/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Physiometrix Inc.
|
Signal processing apparatus and method | ||
Patent #
US 5,482,036 A
Filed 05/26/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 5,490,505 A
Filed 10/06/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Arterial sensor | ||
Patent #
US 5,494,043 A
Filed 05/04/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INC.
|
Alarm for patient monitor and life support equipment | ||
Patent #
US 5,534,851 A
Filed 06/06/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Russek Linda G.
|
Apparatus and method for noninvasive blood pressure measurement | ||
Patent #
US 5,533,511 A
Filed 01/05/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
VITAL INSITE INCORPORATED
|
Positive displacement piston flow meter with damping assembly | ||
Patent #
US 5,562,002 A
Filed 02/03/1995
|
Current Assignee
Sensidyne Inc.
|
Sponsoring Entity
Sensidyne Inc.
|
Headset for electronic stethoscope | ||
Patent #
US 5,561,275 A
Filed 04/28/1994
|
Current Assignee
ANDROMED INC.
|
Sponsoring Entity
Theratechnologies Inc.
|
Method for determining the biodistribution of substances using fluorescence spectroscopy | ||
Patent #
US 5,377,676 A
Filed 03/30/1993
|
Current Assignee
Cedars-Sinai Medical Center
|
Sponsoring Entity
Cedars-Sinai Medical Center
|
Housing for a dental unit disinfecting device | ||
Patent #
D359546S
Filed 01/27/1994
|
Current Assignee
Theratechnologies Inc.
|
Sponsoring Entity
Theratechnologies Inc.
|
Pulse responsive device | ||
Patent #
US 5,431,170 A
Filed 11/25/1992
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Mathews Geoffrey R.
|
Stethoscope head | ||
Patent #
D361840S
Filed 04/21/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Theratechnologies Inc.
|
Stethoscope headset | ||
Patent #
D362063S
Filed 04/21/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Theratechnologies Inc.
|
Finger-cot probe | ||
Patent #
US 5,452,717 A
Filed 06/02/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Stethoscope ear tip | ||
Patent #
D363120S
Filed 04/21/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Theratechnologies Inc.
|
Alarm for patient monitor and life support equipment system | ||
Patent #
US 5,319,355 A
Filed 07/10/1991
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Russek Linda G.
|
Low noise finger cot probe | ||
Patent #
US 5,337,744 A
Filed 07/14/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Electronic stethoscope housing | ||
Patent #
D353195S
Filed 05/28/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Theratechnologies Inc.
|
Stethoscope head | ||
Patent #
D353196S
Filed 05/28/1993
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Theratechnologies Inc.
|
Method and apparatus for continuously and noninvasively measuring the blood pressure of a patient | ||
Patent #
US 5,163,438 A
Filed 09/24/1990
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Paramed Technology Incorporated
|
Oximeter sensor assembly with integral cable and method of forming the same | ||
Patent #
US 5,041,187 A
Filed 10/01/1990
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Thor Technology Corporation
|
Oximeter sensor assembly with integral cable and encoder | ||
Patent #
US 5,069,213 A
Filed 12/19/1989
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
THOR TECHNOLOGY CORPORATION
|
Oximeter sensor assembly with integral cable | ||
Patent #
US 4,964,408 A
Filed 04/29/1988
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
THOR TECHNOLOGY CORPORATION
|
Method and apparatus for continuously and non-invasively measuring the blood pressure of a patient | ||
Patent #
US 4,960,128 A
Filed 11/14/1988
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
PARAMED TECHNOLOGY INCORPORATED A CORP. OF CA
|
Apparatus and method for measuring blood constituents | ||
Patent #
US 4,863,265 A
Filed 10/16/1987
|
Current Assignee
Mine Safety Appliances Company
|
Sponsoring Entity
Mine Safety Appliances Company
|
Interference detector for patient monitor | ||
Patent #
US 8,754,776 B2
Filed 06/14/2013
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Laboratories Inc.
|
20 Claims
- 1. A noninvasive monitor configured to communicate with a sensor including an optical radiation source and one or more detectors housed in a sensor housing, the sensor housing configured to position the optical radiation source and the one or more detectors proximate tissue of a patient, the noninvasive monitor comprising:
an input configured to receive from the sensor first sensor signals responsive to detected light from the optical radiation source attenuated by the tissue and second sensor signals responsive to detected ambient electronic interference proximate the sensor; and a hardware processor configured to; process the first sensor signals to determine a first measurement value for a first physiological parameter of the patient and a second measurement value for a second physiological parameter of the patient without using the second sensor signals to determine the first measurement value and the second measurement value, the first physiological parameter being different from the second physiological parameter, the first physiological parameter corresponding to a first threshold and the second physiological parameter corresponding to a second threshold different from the first threshold, process the second sensor signals differently from the first sensor signals to determine a first level of ambient electronic interference proximate the sensor and a second level of ambient electronic interference proximate the sensor, determine at least one of a first audio or visual indication from a comparison of the first level of ambient electronic interference to the first threshold, the at least one of the first audio or visual indication indicating a suitability of a testing environment for patient monitoring for the first physiological parameter and indicating a degree to which relocating the sensor could reduce ambient electronic interference proximate the sensor, determine at least one of a second audio or visual indication from a comparison of the second level of ambient electronic interference to the second threshold, the at least one of the second audio or visual indication indicating a suitability of the testing environment for patient monitoring for the second physiological parameter and indicating a degree to which relocating the sensor could reduce ambient electronic interference proximate the sensor, output the at least one of the first audio or visual indication for presentation prior to outputting the first measurement value for presentation, and output the at least one of the second audio or visual indication for presentation prior to outputting the second measurement value for presentation. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- 9. A noninvasive monitor configured to communicate with a sensor including an optical radiation source and one or more detectors housed in a sensor housing, the sensor housing configured to position the optical radiation source and the one or more detectors proximate tissue of a patient, the one or more detectors including a detector configured to output a first sensor signal responsive to light attenuated by the tissue and a second sensor signal responsive to ambient electronic interference proximate the sensor, the noninvasive monitor comprising:
an input configured to receive from the sensor the first sensor signal and the second sensor signal; and a hardware processor configured to; process the first sensor signal to determine measurement values for one or more physiological parameters of the patient without using the second sensor signal to determine the measurement values, process the second sensor signal differently from the first sensor signal to determine a level of ambient electronic interference proximate the sensor at a first frequency and a level of ambient electronic interference proximate the sensor at a second frequency different from the first frequency, determine a likelihood of successful processing of the first sensor signal given the level of ambient electronic interference proximate the sensor at the first frequency and the level of ambient electronic interference proximate the sensor at the second frequency, determine at least one of an audio or visual indication from the likelihood of successful processing of the first sensor signal, the at least one of an audio or visual indication indicating a suitability of a testing environment for patient monitoring and indicating a degree to which relocating the sensor could reduce ambient electronic interference proximate the sensor, and output the at least one of the audio or visual indication for presentation prior to outputting the measurement values for presentation. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
1 Specification
The present application is a continuation of U.S. patent application Ser. No. 13/918,206, filed Jun. 14, 2013, entitled “Interference Detector for Patient Monitor,” which is a continuation of U.S. patent application Ser. No. 12/841,965, filed Jul. 22, 2010, entitled “Interference Detector for Patient Monitor,” which claims priority benefit from U.S. Provisional Application No. 61/228,495, filed Jul. 24, 2009, entitled “Interference Detector for Patient Monitor,” the disclosures of which are incorporated herein by reference.
The present application is related to U.S. Pat. No. 5,919,134, filed Jan. 12, 1998, entitled “Method and Apparatus for Demodulating Signals in Pulse Oximetry Systems”; and U.S. Pat. No. 6,526,300, filed Jun. 16, 2000, entitled “Pulse Oximeter Probe-Off Detection System,” both of which are incorporated herein by reference.
The present disclosure relates in general to patient monitoring systems including a patient monitor, one or more optical sensors, and a communication cable or device transferring signals between the monitor and the sensor(s).
Standard of care in caregiver environments includes patient monitoring through spectroscopic analysis using, for example, oximeter technologies commercially available from Masimo Corporation of Irvine. Devices capable of spectroscopic analysis generally include light sources transmitting optical radiation into a measurement site, such as, body tissue carrying pulsing blood. After attenuation (e.g. via transmission through tissue, reflectance, etc.) by tissue and fluids of the measurement site, one or more photodetection devices detects the attenuated light and outputs one or more detector signals responsive to the detected attenuated light. One or more signal processing devices process the detector(s) signal(s) and output a measurement indicative of a blood constituent of interest, such as, glucose, oxygen, methemoglobin, total hemoglobin, other physiological parameters, or other data or combinations of data useful in determining a state or trend of wellness of a patient. Such combinations often include statistical analysis of one or more measurements or combinations of different parameter measurements into useful information.
In addition to the foregoing, considerable efforts have been made to develop noninvasive oximeter techniques for measuring other blood analytes or patient parameters, including for example, glucose, total hemoglobin, or the like. Unfortunately, some of these parameters have proven to be difficult to measure using noninvasive spectroscopy. For example, the biologic tissue and water of a measurement site have a high intrinsic absorption at many of the wavelengths of light that are useful in measuring blood glucose. Moreover, blood glucose exists in relatively low concentrations comparatively with other blood analytes. Furthermore, different patients will have large variations in the optical properties of their skin and blood composition.
Moreover, ambient and/or environment interference (i.e., noise) can adversely affect the measurement accuracy. Interference is generated by many commonly-used electrical devices. In a typical household for example, electric power lines and outlets, ambient lights, light dimmers, television or computer displays, and power supplies or transformers generate electromagnetic interference. For example, noise caused by ambient light will generally vary with a periodicity corresponding to a 50 Hz or 60 Hz fundamental frequency and its harmonics. As will be understood by those of skill in the art, the ambient light frequency is a function of the frequency of electricity powering the ambient lights and other interfering devices and/or the frequency of naturally occurring light. The ambient light frequency will, accordingly, change depending on the power system used to operate the devices creating the ambient light. Harmonics of the fundamental ambient light frequency are important because the ambient light can still cause significant interference at the harmonic frequencies. This is particularly true when the ambient light is provided by fluorescent lights which generate significant noise at the second harmonic (i.e., 100 Hz or 120 Hz) and the fourth harmonic (i.e., 200 Hz or 240 Hz). In addition in typical care environments medical equipment (e.g., electrocauterization devices) also generates significant electromagnetic interference. These and other challenges make signal information indicative of physiological parameters (e.g., glucose) difficult to differentiate from the interference signal. Moreover, patients and other users often desire glucose and other physiological parameter data in at least spot check measurements in a wide variety of care and non-care environments where interference levels are unknown.
In some embodiments of the present disclosure, an interference detector configured to reliably measure the levels of ambient and/or environment interference is described. The detector utilizes frequency analysis to determine and calculate interference levels in the frequency bands of interest. Such bands of interest can be configured to be those frequencies used for analysis during measuring the various physiological parameters. For example, a modulated light signal attenuated by body tissue or fluids can comprise physiological information at the fundamental frequency and harmonic frequencies of the carrier signal (e.g., a periodic pulse train). Interference levels can be measured at the fundamental frequency and harmonic frequencies to determine the likelihood of obtaining reliable measurements of physiological parameters in the presence of ambient and/or environment noise.
In some embodiments of the present disclosure, the interference levels can be computed as energy or power of interference signals concentrated at the frequencies of interest. The maximum measured power can be used to determine the worst-case effect of ambient and/or environmental interference on the accuracy of measurements of physiological parameters. This maximum measured power can be compared with a threshold to obtain an objective determination of the significance of the interference and its expected degradation of the accuracy of the measurements. The threshold can be selected as a multiple of the noise floor of the interference detector or, in other words, the measured noise signal that is inherently present in the system because of thermal noise, shot noise, and the like. The noise floor further establishes a limit on the smallest measurement that can be reliably preformed by the system. The multiple of the noise floor and the threshold can be varied depending on the type of physiological parameter being measured by the device.
In some embodiments of the present disclosure, the interference detector can be configured to provide audio-visual indication of the measured interference levels, relative to the threshold, to the user. Visual indication can comprise displaying bar graphs, charts, graphs, and the like of the measured, relative interference levels. Audio indication can comprise speaking the severity of the measured, relative interference levels. Audio-visual indication can be helpful in spot check measurement situations because the user can be quickly informed as to the expected accuracy of the measurement of physiological parameters. In addition, the user can be quickly alerted in situations where ambient and/or environmental interference can significantly degrade the measurement accuracy or cause the measurements be unreliable.
For purposes of summarizing the invention, certain aspects, advantages and novel features of the invention have been described herein. Of course, it is to be understood that not necessarily all such aspects, advantages or features will be embodied in any particular embodiment of the invention.
The following drawings and the associated descriptions are provided to illustrate embodiments of the present disclosure and do not limit the scope of the claims.
Ambient and/or environment interference (i.e., noise) can adversely affect the measurement accuracy of non-invasive patient monitoring systems, such as systems capable of measuring glucose, oxygen, methemoglobin, total hemoglobin, and other physiological parameters. To perform the measurements, these systems typically utilize signal processing analysis of optical radiation (e.g., light) signal detected by photodetectors after it has been attenuated by body tissue and fluids. However, significant interference is generated by many commonly-used electrical devices, such as electric power lines and outlets, ambient lights, light dimmers, television or computer displays, power supplies or transformers, and medical equipment (e.g., electrocauterization devices). It can be difficult to differentiate signal information indicative of physiological parameters from the interference. Moreover, patients and other users often desire glucose and other physiological parameter data in at least spot check measurements in a wide variety of care and non-care environments where the interference levels are unknown.
Existing solutions for measuring the interference levels can be inadequate, especially in spot check situations. For example, one approach is to measure the interference at the same time as performing measurements of physiological parameters. However, this can be unreliable because interference may be highly non-stationary and non-periodic, may have short-duration components with significant energy levels, and so on. Accordingly, such measurements of interference levels can be inaccurate and unreliable.
In some embodiments of the present disclosure, an interference detector configured to reliably measure the interference levels is described. The detector utilizes frequency analysis to determine and calculate interference levels in the frequency bands of interest. Such bands of interest can be configured to be those frequencies used for analysis during measuring the various physiological parameters. For example, a modulated light signal attenuated by body tissue or fluids can comprise physiological information at the fundamental frequency and harmonic frequencies of the carrier signal (e.g., a periodic pulse train). Interference levels can be measured at the fundamental frequency and harmonic frequencies to determine the likelihood of obtaining reliable measurements of physiological parameters in the presence of ambient and/or environment noise. In some embodiments, the interference levels can be used to determine a best modulation rate that will result in the least interference to the desired signal.
In some embodiments of the present disclosure, the interference levels can be computed as energy or power of interference signals concentrated at the frequencies of interest. The maximum measured power can be used to determine the worst-case effect of ambient and/or environmental interference on the accuracy of measurements of physiological parameters. This maximum measured power can be compared with a threshold to obtain an objective determination of the significance of the interference and its expected degradation of the accuracy of the measurements. The threshold can be selected as a multiple of the noise floor of the interference detector or, in other words, the measured noise signal that is inherently present in the system because of thermal noise, shot noise, and the like. The noise floor further establishes a limit on the smallest measurement that can be reliably performed by the system. The multiple of the noise floor and the threshold can be varied depending on the type of physiological parameter being measured by the device.
In some embodiments of the present disclosure, the interference detector can be configured to provide audio-visual indication of the measured interference levels, relative to the threshold, to the user. Visual indication can comprise displaying bar graphs, charts, graphs, and the like of the measured, relative interference levels. Audio indication can comprise speaking the severity of the measured, relative interference levels. Audio-visual indication can be helpful in spot check measurement situations because the user can be quickly informed as to the expected accuracy of the measurement of physiological parameters. In addition, the user can be quickly alerted in situations where ambient and/or environmental interference can significantly degrade the measurement accuracy or cause the measurements be unreliable.
To facilitate a complete understanding of the invention, the remainder of the detailed description describes the invention with reference to the drawings, wherein like reference numbers are referenced with like numerals throughout.
The patient monitor can comprise a display 110 and one or more control buttons 108. In some embodiments, the display 110 can be a touch sensitive display that can include one or more virtual controls and/or changing display and/or control screens. The display 110 can be configured to display a wide variety of measured psychological parameters in a manner that provides for quick and efficient conveyance of information to a user. For example, the display 110 can show values for blood oxygen saturation, pulse, glucose, methemoglobin, total hemoglobin, and the like. In addition, as shown in
The sensor 202 can additionally comprise a temperature sensor 207, such as a thermistor or a thermocouple, and a memory device 208, such non-volatile (e.g., an EEPROM) or volatile memory. The sensor 202 also includes a plurality of conductors communicating signals to and from its components, including temperature sensor conductors 209, detector composite signal conductors 210, memory device conductors 214, and emitter drive signal conductors 216. In some embodiments, the sensor conductors 209, 210, 214, 216 communicate their signals to the monitor 203 through the cable 212. In some embodiments, the cable 212 includes a plurality of shielded conductors.
Although disclosed with reference to the cable 212, a skilled artisan will recognize from the disclosure herein that the communication to and from the sensor 202 may advantageously include a wide variety of cables, cable designs, public or private communication networks or computing systems, wired or wireless communications (such as Ethernet, Bluetooth or WiFi, including IEEE 802.11x), mobile communications, combinations of the same, or the like.
In some embodiments, the temperature sensor 207 monitors the temperature of the sensor 202 and its components, such as, for, example, the emitters 204. For example, in some embodiments, the temperature sensor 207 comprises or communicates with a thermal bulk mass having sufficient thermal conduction to generally approximate a real-time temperature of a substrate of the light emitters 204. In some embodiments, the monitor 203 may advantageously use the temperature sensor 207 output to, among other things, ensure patient safety, especially in applications with sensitive tissue 205. In some embodiments, the monitor 203 may advantageously use the temperature sensor 207 output and monitored operating current or voltages to correct for operating conditions of the sensor 202.
The memory 208 can comprise any one or more of a wide variety of memory devices known to a skilled artisan from the disclosure herein, including non-volatile memory, volatile memory, or combination thereof. The memory 208 can be configured to store some or all of a wide variety data and information, including, for example, information on the type or operation of the sensor 202, type of patient or body tissue 205, buyer or manufacturer information, sensor characteristics including the number of wavelengths capable of being emitted, emitter specifications, emitter drive requirements, demodulation data, calculation mode data, calibration data, software or firmware such as scripts, executable code, or the like, sensor electronic elements, sensor life data indicating whether some or all sensor components have expired and should be replaced, encryption information, monitor or algorithm upgrade instructions or data, or the like. In some embodiments, the memory device 208 may also include emitter wavelength correction data. In some embodiments, the monitor 203 can read the memory 208 to determine one, some or all of a wide variety of data and information stored. As is shown In
The monitor 203 can comprise a front end signal conditioner 222 configured to receive, through the conductors 210, the analog composite detector signal from the detectors 206. The signal conditioner 222 can normalize the analog composite detector signal by adjusting the signal'"'"'s gain, remove unwanted frequency components by passing the signal through a band-pass or a low-pass filter, normalize the phase of the signal by passing it through an all-pass filter with the desired phase response, and the like. The signal conditioner 222 includes one or more outputs communicating with an analog-to-digital converter 226 (“A/D converter”). In some embodiments, the A/D converter 226 may comprise a delta-sigma converter to provide better linearity and signal-to-noise performance, which, among other things, advantageously enhances measurements during lower perfusion. The reduced signal-to-noise may also improve measurement quality by providing better rejection of ambient and/or environment interference (e.g., from electrocauterization devices). The A/D converter 226 includes inputs communicating with the output of the front end signal conditioner 222 and the output of the temperature sensor 207. The converter 226 also includes outputs for communicating the digitized composite detector signal values and temperature sensor readings to the processor 228.
The processor 228 can output an emitter driver current control signal 230 to a digital-to-analog converter 232 (“D/A converter”). The D/A converter 232 can supply control information to emitter driving circuitry 234, which in turns drives the plurality of emitters 204 on the sensor 202 over conductors 216. In some embodiments, the emitter driving circuitry 234 drives eight emitters capable of emitting light at eight predefined wavelengths, although the circuitry 234 can drive any number of emitters. In addition, one or more emitters could emit light at the same or substantially the same wavelength to provide redundancy. The circuitry 234 can be configured to modulate the emitters 204, by turning them on and off, as to produce pulse trains of light at the corresponding wavelengths. In some embodiments, the circuitry 234 can be configured to turn the emitters 204 off as to cause the detectors 206 to detect the level of ambient or environment noise, which can additionally modulate by the rectangular pulse train carrier signal. Further details of modulation are disclosed in U.S. Pat. No. 6,229,856, issued on May 8, 2001, the disclosure of which is incorporated by reference herein.
The processor 228 can process digitized composite detector signal values and calculate physiological parameter information, such as blood oxygen saturation, pulse, glucose, methemoglobin, total hemoglobin, and the like. The processor 228 comprises an interference detector 240 configured to calculate the levels of ambient and/or environment interference comprised in the composite detector signal. In some embodiments, the processor 228 can read the information stored in the memory device 208 and use the retrieved information for calculation of physiological parameter information and/or interference levels.
The processor 228 can communicate with the audio/visual interface 236, for example, to display the measured and calculated parameters or interference levels.
The audio/visual interface 236 can be configured as a display device capable of providing indicia representative of the calculated physiological parameters of the tissue 205 at the measurement site and of the calculated interference levels. In some embodiments, the audio/visual interface 236 can display trending data for one or more of the measured or determined parameters or interference levels. Moreover, an artisan will recognize from the disclosure herein many display options for the data available from the processor 228.
In addition, the processor 228 can communicate with local and/or remote storage 241 and local and/or remote network devices through network interface 242. Storage 241 can be configured as non-volatile memory, volatile memory or combination thereof. Storage 241 can be in the form of a hard disk, flash memory card, or other suitable computer accessible memory. In some embodiments, the processor 228 can store a variety of information in the storage 241, such as calculated physiological parameter information and interference levels. This information can be later retrieved and used in future calculations. In some embodiments, the processor can communicate variety of information to network devices over the network interface 242. The network interface 242 can be configured with a wide variety of cables, cable designs, public or private communication networks or computing systems, wired or wireless communications (such as Ethernet, Bluetooth or WiFi, including IEEE 802.11x), mobile communications, combinations of the same, or the like. The processor 228 can exchange a variety of information with network devices, such as calculated physiological parameter information and interference levels.
In some embodiments a demodulation module 403A models and demodulates the digitized composite detector signal 401A (e.g., a 48 KHz composite signal) to separate the composite signal into signals related to each emitted wavelength and to remove the frequency components of the carrier signal. In addition, the demodulation module 403A can be configured to model and demodulate the digitized composite detector signal to separate the interference signal into interference signals related to each emitted wavelength and to remove the frequency components of the carrier signal. In some embodiments the demodulation module 403A can be configured to model and demodulate digitized composite detector signal data into N (e.g., 8) channels of demodulated data. Each channel can be configured to correspond to a different frequency and/or phase characteristics. For example, each channel can correspond to a fundamental frequency and its harmonics of the rectangular light pulse train carrier signal modulated by the light signal emitted by an emitter 204. Furthermore, as explained below, several channels can share the same frequency characteristic, and, in such embodiments, phase can be used to distinguish these channels.
The multiple channels of demodulated data samples can be presented to a decimation module 404A, which is configured to reduce the sampling rate by eliminating samples and, additionally, may provide signal conditioning and filtering. Because decimation reduces the number of data samples, it can reduce computational burden on the digital signal processor and interference detector 428 and, additionally, reduce power consumption of the patient monitor. In some embodiments, a 48 KHz demodulated multiple channel data stream can be decimated to 62.5 Hz.
To determine the interference levels, the multiple channels of demodulated and decimated data can be presented to an energy detector 405A. In some embodiments, the composite detector signal xk(n) 401A can comprise only the interference signal, as the emitters 204 can be configured (e.g., by the circuitry 234) to be off. Then, the multiple channels of demodulated and decimated data comprise interference signals, and the energy detector 405A can be configured to compute the energy or power of the interference signals. In some embodiments, as is explained below, the energy detector 405A can compute the average power of the interference signal on each of the decimation channels and to select the maximum power value as the interference output.
To compute physiological parameter information, such as blood oxygen saturation, pulse, glucose, methemoglobin, total hemoglobin, and the like, the multiple channels of demodulated and decimated data can be presented to a parameter calculator 406A. The parameter calculator 406A can model, condition, and process the data according to various algorithms for computation of physiological information, as is described in U.S. application Ser. No. 11/367,017 (filed Mar. 1, 2006), the disclosure of which is incorporated by reference herein.
A demodulation module 403B models and demodulates the digitized composite detector signal xk(n) 401B (e.g., a 48 KHz composite signal) to separate the interference signal into interference signals related to each emitted wavelength and to remove the frequency components of the carrier signal. As is illustrated in
In some embodiments, a modulated light signal can be produced by modulating a periodic, rectangular pulse train (i.e., the carrier signal) by the light produced by the emitters 204. The circuit 234 can be configured such that only one emitter 204 (e.g., light emitting diodes) is active at any given time period. For example, if there are two emitters 204 (e.g., red and infrared light emitting diodes), the circuit 234 can apply current to activate the first emitter during a first time interval of duration τ1, while keeping the second emitter inactive. Thereafter, no current can be applied to either emitter during a second time interval of duration τ2. Then, the current can be applied to activate the second emitter during a third time interval of duration τ3, while keeping the first emitter inactive. Finally, the modulation cycle can be completed by applying no current to either emitter during a fourth time interval τ4. Thereafter, the cycle can be repeated by restarting with the first interval. All four time intervals τ1, τ3, τ3, and τ4 can be of the same duration τ. Accordingly, the carrier signal, a periodic, rectangular pulse train having a pulse width τ and a period of 4τ and corresponding Fourier coefficients of τF0·sin c(kF0τ), where F0 is the fundamental frequency (i.e. inverse of the period) and k=±1, ±2, . . . , is modulated by the light emitted by emitters 204. The Fourier coefficients correspond to the fundamental frequency and its harmonics (or integer multiples of the fundamental frequency). The circuit 234 can be configured to similarly modulate any number of carrier signals by any number of emitters 204, such as 8 emitters.
In order to recover the intensity of the light signal, attenuated through the tissue 205 and detected by the detectors 206, the demodulation module 403B can be configured to model and analyze the composite detector signal 401B at the fundamental frequency F0 and the harmonics of the periodic pulse train (“frequencies of interest”). This can be accomplished by shifting the envelope of the modulated signal (i.e. composite detector signal), or part of the envelope that comprises a significant energy of the intensity signal, to a frequency of interest and then applying a filter to remove components at other higher frequencies. In some embodiments, several frequencies of interest can be used and shifting of the envelope can be accomplished by multiplying the modulated signal by a cosine or sine signal having the frequency corresponding to the frequency of interest. A skilled artisan will recognize from the disclosure herein that frequencies of interest can be frequencies other than the fundamental frequency F0 and its harmonics and demodulations methods other than shifting the signal envelope can be used.
In some embodiments, the demodulation module 403B can be further configured to reduce or eliminate in the composite detector signal crosstalk between the light signals output by different emitters 204. For example, if there are two emitters 204 (e.g., red and infrared light emitting diode), crosstalk in the composite detector signal can be defined as the effect of the red light signal on the infrared light signal and vice versa. Such crosstalk can be minimized or eliminated by selecting appropriate demodulating signals and multiplying these by the composite detector signal. In some embodiments as is explained in the above-identified issued U.S. Pat. No. 6,229,856, demodulating signals reducing or eliminating crosstalk can be configured as cosine signals with frequencies of the fundamental frequency F0 and harmonics of the carrier pulse train: C1 cos(2πF0t), C2 cos(4πF0t), C3 cos(6πF0t), and so on (where C1, C2, C3, . . . are constants selected to minimize or eliminate crosstalk).
Additionally, selecting frequencies of interest can result in reducing the effect of at least some types and intensities of ambient or environment noise on the light intensity signals. For example, the fundamental frequency F0 can be selected as 316.7 Hz (i.e., with harmonics at 316.7n Hz, where n is an integer value) to reduce or eliminate the effect of power line noise (60 Hz or 50 Hz fundamental frequency with harmonics at 60n Hz or 50n Hz, where n is an integer value). Accordingly, the nearest harmonic of power line noise to the light signal intensity comprised by the modulated pulse train having the fundamental frequency of 316.7 Hz would be 300 and 360 Hz, for 60 Hz power line frequency, and 300 and 350 Hz, for 50 Hz power line frequency. This would provide a frequency separation of noise and light intensity. In some embodiments, the fundamental frequency F0 can be selected as 330 Hz to provide the separation.
Accordingly, in some embodiments, the demodulation module 403B of the interference detector 440B can be configured to model and analyze the composite detector signal 401B, which comprises interference, at the fundamental frequency F0 and its harmonics. Accordingly, the demodulation module 403B operates at the modulation frequency and its harmonics as applied to demodulate the modulated composite light signal. As is explained above, interference signals having components at these frequencies of interest can significantly degrade the recovery of the light intensity signals from the composite detector signal. Therefore, it is advantageous to determine the level of interference at these frequencies of interest and to compute the likelihood of successful recovery and processing of the light intensity signals given in the presence of ambient and/or environment interference. In some embodiments, the demodulation module 403B can be configured to model the interference signal at the fundamental frequency and the second, third, and fourth harmonics. However, a skilled artisan will recognize a wide variety of signal modeling combinations from the disclosure herein.
Furthermore, the demodulation module 403B can be configured to model the full energy spectrum of the interference signal at the frequencies of interest. This can be accomplished by capturing the energy of the interference signal at the frequencies of interest regardless of the phase variation of the interference signal at those frequencies. In some embodiments, this can be accomplished by using both cosine and sine as demodulating signals. Because cosine and sine signals of the same frequency are π/2 radians out of phase, using these as complementary demodulating signals can model and capture all of the potential interference signal energy at the frequencies of interest. In some embodiments, the spectrum of the interference signal can be modeled by using only a cosine or only a sine demodulating signal. A skilled artisan will recognize a wide variety of demodulating signals, such as orthogonal signals, from the disclosure herein.
As is illustrated in
The demodulated interference signal data can be presented to a decimation module 404B, which reduces the sampling rate by eliminating samples and, additionally, may provide signal conditioning and filtering. Because decimation reduces the number of data samples, it can reduce computational burden on the interference detector 440B and, additionally, reduce power consumption of the patient monitor. As is illustrated in
The demodulated, decimated interference signal data can be presented to an energy detector 405B for calculation of interference levels. A signal'"'"'s energy can be calculated by summing up squared absolute values of the signal samples. As is illustrated in
In some embodiments, the calculated energy or power computed for complementary cosine and sine channels sharing the same frequency can be summed in order to determine energy or power of the interference signal at each frequency of interest. As is explained above, because cosine and sine signals of the same frequency are π/2 radians out of phase, using both as complementary demodulating signals can model and capture all of the potential interference signal energy at the frequencies of interest. As is illustrated in
The interference level (or output) computed by the interference detector 440B for the digitized composite detector signal xk(n) 401B can be the maximum computed energy or power at the frequencies of interest. As is illustrated in
The maximum computed energy or power of the interference signal (or interference output) can be communicated to the user at 507. In some embodiments, the interference output can be presented to the user visually as, for example, in a bar graph. As is illustrated in
As is illustrated in
In some embodiments, the patient monitor can be configured to provide audio notification to the user. For example, after computing the interference output and comparing it to the threshold, the patient monitor can sound the phrase “Safe to Measure” when the interference output is below the threshold. As another example, the patient monitor can sound the phrase “Danger” when the interference output is close or above the threshold. A skilled artisan will recognize a variety of audio/visual notification techniques from the disclosure herein.
Although the interference detector for a patient monitor is disclosed with reference to its preferred embodiment, the invention is not intended to be limited thereby. Rather, a skilled artisan will recognize from the disclosure herein a wide number of alternatives for the interference detector for patient monitor. For example, the patient monitor can “lock out” the user from performing measurements of physiological parameters when the computed interference levels are determined to significantly degrade the accuracy of the measurements.
In addition to those processes described above, other processes and combination of processes will be apparent to those of skill in the art from the present disclosure. Those of skill will further appreciate that the various illustrative logical blocks, modules, and steps described in connection with the embodiments disclosed herein may be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. Skilled artisans can implement the described functionality in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the present invention.
The various illustrative logical blocks, modules, and steps described in connection with the embodiments disclosed herein can be implemented or performed with a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, conventional processor, controller, microcontroller, state machine, etc. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. In addition, the term “processing” is a broad term meant to encompass several meanings including, for example, implementing program code, executing instructions, manipulating signals, filtering, performing arithmetic operations, and the like.
The modules can include, but are not limited to, any of the following: software or hardware components such as software, object-oriented software components, class components and task components, processes, methods, functions, attributes, procedures, subroutines, segments of program code, drivers, firmware, microcode, circuitry, data, databases, data structures, tables, arrays, or variables.
The steps of a method or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, a DVD, or any other form of storage medium known in the art. A storage medium is coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.
Although the foregoing invention has been described in terms of certain preferred embodiments, other embodiments will be apparent to those of ordinary skill in the art from the disclosure herein. Additionally, other combinations, omissions, substitutions and modifications will be apparent to the skilled artisan in view of the disclosure herein. It is contemplated that various aspects and features of the invention described can be practiced separately, combined together, or substituted for one another, and that a variety of combinations and subcombinations of the features and aspects can be made and still fall within the scope of the invention. Furthermore, the systems described above need not include all of the modules and functions described in the preferred embodiments. Accordingly, the present invention is not intended to be limited by the reaction of the preferred embodiments, but is to be defined by reference to the appended claims.
Additionally, all publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.